Cardiol Therapeutics Inc.
CRDL.TO
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.22M | -24.89M | -26.99M | -25.77M | -26.80M |
| Total Depreciation and Amortization | 73.00K | 89.00K | 217.80K | 244.60K | 272.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.62M | 6.87M | 9.68M | 8.14M | 8.91M |
| Change in Net Operating Assets | -524.70K | 635.20K | -872.90K | -786.60K | -703.80K |
| Cash from Operations | -17.05M | -17.30M | -17.97M | -18.17M | -18.32M |
| Capital Expenditure | -17.40K | -19.60K | -23.20K | -21.30K | -15.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -17.40K | -19.60K | -23.20K | -21.30K | -15.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -55.20K | -55.20K | -46.00K | -41.40K | -41.40K |
| Issuance of Common Stock | 16.07M | 21.39M | 21.39M | 21.44M | 21.53M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -477.00K | -2.65M | -2.65M | -2.65M | -2.65M |
| Cash from Financing | 11.15M | 13.35M | 13.35M | 13.40M | 13.46M |
| Foreign Exchange rate Adjustments | -588.70K | 933.30K | 405.20K | 920.10K | 1.36M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.51M | -3.04M | -4.23M | -3.87M | -3.51M |